About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Massachusetts | 382 Studies

Clinical Trials Pancreatic CancerMassachusetts

Pancreatic Cancer Clinical Trials in Massachusetts

Find 382 clinical trials for pancreatic cancer near Massachusetts. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 382 trials

TerminatedNeoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerThe purpose of this research study is to determine if it is possible to deliver high dose radiation in one week while also giving the drug capecitabine for the treatment of…NCT00889187·Boston, Massachusetts and 2 others CompletedGenetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersThis study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.NCT04330716·Boston, Massachusetts and 5 others CompletedPembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsThis is an open-label, multicenter, Phase 1b platform study in subjects with advanced or metastatic solid tumors (Part 1a) and subjects with selected solid tumors (Part 1b and…NCT02646748·San Francisco, California and 16 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationThis is an open-label, multi-center, phase 1b study designed to determine a tolerable dose of CX-5461 administered by IV infusion on Day 1 and Day 8 of a 28-day cycle in patients…NCT04890613·Santa Monica, California and 7 others

CompletedGemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00057876·Phoenix, Arizona and 228 others

Active not recruitingBiological Sample Repository for Gastrointestinal DisordersThe goal of this observational study has the purpose of collecting biological samples from obese patients undergoing evaluation for weight loss by means of medical or endoscopic…NCT05874726·Boston, Massachusetts

TerminatedPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsA Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.NCT03685591·Scottsdale, Arizona and 14 others

CompletedStudy of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced CancersPhase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab in advanced solid tumors.NCT02526017·Scottsdale, Arizona and 38 others

CompletedPre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)The purpose of this research study is to see if a specific kind of MRI, called Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI), which uses an…NCT00920023·Boston, Massachusetts

CompletedGemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic CancerThe question being asked in this study is: Will patients with advanced pancreatic cancer live significantly longer if they are treated with a combination of Gemcitabine and ON…NCT01360853·La Jolla, California and 45 others

RecruitingStudy of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsThe purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with…NCT06445062·Chandler, Arizona and 31 others

RecruitingNano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic CancerThis research study is being done to help determine the safety and efficacy of gadolinium based nanoparticle, Activation and Guidance of Irradiation X (AGuIX), used in conjunction…NCT04789486·Boston, Massachusetts and 1 other

CompletedEarly Palliative Care in Advanced Lung and Gastrointestinal MalignanciesThe purpose of this study is to compare two types of care - standard oncology care and standard oncology care with early palliative care (started soon after diagnosis) to see…NCT01401907·Boston, Massachusetts

RecruitingA Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismThe objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug as add-on to standard of care (SOC) therapy for treatment of hypoglycemia…NCT06881992·Chicago, Illinois and 12 others

TerminatedA Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesA Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homologous Recombination…NCT04171700·Los Angeles, California and 18 others

TerminatedA Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsThis study will test the safety of a drug called PF-08046049/SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or have spread through the body.NCT05571839·Los Angeles, California and 36 others

TerminatedVapreotide in Treating Patients Undergoing Elective Pancreatic ResectionRATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection.NCT00014651·Birmingham, Alabama and 17 others

UnknownPilot Study of a Multimodal Prehabilitation Pancreatic Cancer ProgramThe purpose of this research is to explore the benefits of an exercise and nutrition program during total neoadjuvant therapy (TNT) in preparation for surgery for participants…NCT03865875·Boston, Massachusetts

RecruitingStudy of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASEvaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.NCT05379985·Orange, California and 20 others

CompletedLYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsA Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemotherapy or Tislelizumab in…NCT04666688·Los Angeles, California and 11 others

Page 1 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia